Perindopril Arginine/Amlodipine 5/5 APOTEX tablet perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/5 apotex tablet perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL-TAV perindopril arginine 5mg film-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril-tav perindopril arginine 5mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maltodextrin; colloidal anhydrous silica; glycerol dibehenate; sodium starch glycollate type a; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL ARGININE ACTAVIS perindopril arginine 5mg film-coated tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril arginine actavis perindopril arginine 5mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; maltodextrin; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-AS perindopril arginine 10mg film-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril-as perindopril arginine 10mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; glycerol dibehenate; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-VIS perindopril arginine 2.5mg film-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril-vis perindopril arginine 2.5mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; glycerol dibehenate; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-ZP perindopril arginine 5mg film-coated tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril-zp perindopril arginine 5mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; maltodextrin; glycerol dibehenate; sodium starch glycollate type a; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-VIS perindopril arginine 10mg film-coated tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

perindopril-vis perindopril arginine 10mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; maltodextrin; colloidal anhydrous silica; lactose monohydrate; sodium starch glycollate type a; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.